. Referanser

Agustsson, T. T., Baldvinsdottir, T., Jonasson, J. G., Olafsdottir, E., Steinthorsdottir, V., Sigurdsson, G., . . . Benediktsson, R. (2015). The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. European Journal of Endocrinology of the European Federation of Endocrine Societies, 173(5), 655-664. https://doi.org/10.1530/eje-15-0189

Ajithkumar, T., & Brada, M. (2004). Stereotactic linear accelerator radiotherapy for pituitary tumors. Treatments in Endocrinology, 3(4), 211-216. https://doi.org/10.2165/00024677-200403040-00002

Becker, G., Kocher, M., Kortmann, R. D., Paulsen, F., Jeremic, B., Müller, R. P., & Bamberg, M. (2002). Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlentherapie und Onkologie, 178(4), 173-186. https://doi.org/10.1007/s00066-002-0826-x

Bengtsson, D., Schrøder, H. D., Andersen, M., Maiter, D., Berinder, K., Feldt Rasmussen, U., . . . Burman, P. (2015). Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide. Journal of Clinical Endocrinology and Metabolism, 100(4), 1689-1698. https://doi.org/10.1210/jc.2014-4350

Brada, M., Burchell, L., Ashley, S., & Traish, D. (1999). The incidence of cerebrovascular accidents in patients with pituitary adenoma. International Journal of Radiation Oncology, Biology, Physics, 45(3), 693-698. https://doi.org/10.1016/s0360-3016(99)00159-5

Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., . . . Karlsson, F. A. (2013). Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. Journal of Clinical Endocrinology and Metabolism, 98(4), 1466-1475. https://doi.org/10.1210/jc.2012-4059

Daly, A. F., & Beckers, A. (2015). Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocrinology and Metabolism Clinics of North America, 44(1), 19-25. https://doi.org/10.1016/j.ecl.2014.10.002

Dekkers, O. M., Pereira, A. M., & Romijn, J. A. (2008). Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. Journal of Clinical Endocrinology and Metabolism, 93(10), 3717-3726. https://doi.org/10.1210/jc.2008-0643

Ding, D., Starke, R. M., & Sheehan, J. P. (2014). Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy. Journal of Neuro-Oncology, 117(3), 445-457. https://doi.org/10.1007/s11060-013-1262-8

Eaton, D. J., Lee, J., Patel, R., Millin, A. E., Paddick, I., & Walker, C. (2018). Stereotactic radiosurgery for benign brain tumors: Results of multicenter benchmark planning studies. Practical Radiation Oncology, 8(5), e295-e304. https://doi.org/10.1016/j.prro.2018.02.006

Erridge, S. C., Conkey, D. S., Stockton, D., Strachan, M. W., Statham, P. F., Whittle, I. R., . . . Gregor, A. (2009). Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiotherapy and Oncology, 93(3), 597-601. https://doi.org/10.1016/j.radonc.2009.09.011

Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., & Vance, M. L. (2011). Pituitary incidentaloma: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96(4), 894-904. https://doi.org/10.1210/jc.2010-1048

Freda, P. U., Wardlaw, S. L., & Post, K. D. (1996). Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. Journal of Clinical Endocrinology and Metabolism, 81(10), 3455-3459. https://doi.org/10.1210/jcem.81.10.8855784

Frieze, T. W., Mong, D. P., & Koops, M. K. (2002). "Hook effect" in prolactinomas: case report and review of literature. Endocrine Practice, 8(4), 296-303. https://doi.org/10.4158/ep.8.4.296

Gnanalingham, K. K., Bhattacharjee, S., Pennington, R., Ng, J., & Mendoza, N. (2005). The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. Journal of Neurology, Neurosurgery and Psychiatry, 76(3), 415-419. https://doi.org/10.1136/jnnp.2004.035576

Gravdahl, G. B., Tronvik, E. A., Fougner, S. L., & Solheim, O. (2016). Pituitary Adenoma and Non-acute Headache: Is There an Association, and Does Treatment Help? World Neurosurgery, 92, 284-291. https://doi.org/10.1016/j.wneu.2016.04.071

Hurel, S. J., Thompson, C. J., Watson, M. J., Harris, M. M., Baylis, P. H., & Kendall-Taylor, P. (1996). The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology, 44(2), 141-146. https://doi.org/10.1046/j.1365-2265.1996.555381.x

Jørgensen, A. P., Tazmini, K., & red. (8. april 2020). Nasjonal veileder i endokrinologi. [nettdokument]. Oslo: Norsk Endokrinologisk Forening. Retrieved 8. juni 2020, from https://www.endokrinologi.no/

Kaltsas, G. A., Evanson, J., Chrisoulidou, A., & Grossman, A. B. (2008). The diagnosis and management of parasellar tumours of the pituitary. Endocrine-Related Cancer, 15(4), 885-903. https://doi.org/10.1677/erc-08-0170

Kong, D. S., Lee, J. I., Lim, D. H., Kim, K. W., Shin, H. J., Nam, D. H., . . . Kim, J. H. (2007). The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer, 110(4), 854-860. https://doi.org/10.1002/cncr.22860

Kontogeorgos, G. (2005). Classification and pathology of pituitary tumors. Endocrine, 28(1), 27-35. https://doi.org/10.1385/endo:28:1:027

Landberg, T., Chavaudra, J., Dobbs, J., Gerard, J. P., Hanks, G., Horiot, J. C., . . . Svensson, H. (1999). Report 62: prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU report 50). Journal of the International Commission on Radiation Units and Measurements, os32(1).

Landberg, T., Chavaudra, J., Dobbs, J., Hanks, G., Johansson, K.-A., Möller, T., & Purdy, J. (1993). Report 50: Prescribing, Recording, and Reporting Photon Beam Therapy. Journal of the ICRU, os26(1).

Leve med kreft: nasjonal kreftstrategi (2018–2022). (2018). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/no/dokumenter/leve-med-kreft/id2598282/

Levernes, S. (2012). Volum og doser i ekstern stråleterapi: definisjoner og anbefalinger (StrålevernRapport 2012:9). Østerås: Statens strålevern. Retrieved from https://dsa.no/medisinsk-stralebruk/kvist/_/attachment/download/bee8860b-36d1-42e7-8d64-f5ad4fcef2e8:8ebb86decddc2818ec31e4999d26cdf7aec14ac2/StralevernRapport_09-2012.pdf

Levernes, S. (2019). Faglige anbefalinger for nomenklatur for volumer i stråleterapi (Teknisk dokument 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Retrieved from https://dsa.no/publikasjoner/_/attachment/download/9d2a42a5-241e-4299-86cf-6b02a0abf3b9:2400dff7cb71f4bff583473d690fcb79650dd59e/TekniskDokument14_rev2020.pdf

Loeffler, J. S., & Shih, H. A. (2011). Radiation therapy in the management of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 96(7), 1992-2003. https://doi.org/10.1210/jc.2011-0251

Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). LOV-2011-06-24-30. Last update in LOV-2019-06-21-45 fra 01.01.2020. Retrieved from https://lovdata.no/dokument/NL/lov/2011-06-24-30

Marienhagen, K., Djupvik, L. H., & Danielsen, T. (2020). Faglige anbefalinger for inntegning av risikoorganer i CNS (Teknisk dokument 16). Østerås: Direktoratet for strålevern og atomsikkerhet. Retrieved from https://dsa.no/publikasjoner/_/attachment/download/401a60b3-b7db-4c4a-b741-da0a70c43b20:f0c3325a0ec4a43b2335cf17df266e4e7c34408c/Teknisk%20dokument16_rev.pdf

Miermeister, C. P., Petersenn, S., Buchfelder, M., Fahlbusch, R., Lüdecke, D. K., Hölsken, A., . . . Buslei, R. (2015). Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications. Acta neuropathologica communications, 3, 50. https://doi.org/10.1186/s40478-015-0229-8

Minniti, G., Clarke, E., Scaringi, C., & Enrici, R. M. (2016). Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 21(4), 370-378. https://doi.org/10.1016/j.rpor.2014.09.004

Minniti, G., Flickinger, J., Tolu, B., & Paolini, S. (2018). Management of nonfunctioning pituitary tumors: radiotherapy. Pituitary, 21(2), 154-161. https://doi.org/10.1007/s11102-018-0868-4

Minniti, G., Gilbert, D. C., & Brada, M. (2009). Modern techniques for pituitary radiotherapy. Reviews in Endocrine & Metabolic Disorders, 10(2), 135-144. https://doi.org/10.1007/s11154-008-9106-0

Minniti, G., Osti, M. F., & Niyazi, M. (2016). Target delineation and optimal radiosurgical dose for pituitary tumors. Radiation Oncology (London, England), 11(1), 135. https://doi.org/10.1186/s13014-016-0710-y

Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011). Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 96(6), 1587-1609. https://doi.org/10.1210/jc.2011-0179

Murad, M. H., Fernández-Balsells, M. M., Barwise, A., Gallegos-Orozco, J. F., Paul, A., Lane, M. A., . . . Montori, V. M. (2010). Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clinical Endocrinology, 73(6), 777-791. https://doi.org/10.1111/j.1365-2265.2010.03875.x

Müller, H. L., Merchant, T. E., Puget, S., & Martinez-Barbera, J. P. (2017). New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nature Reviews: Endocrinology, 13(5), 299-312. https://doi.org/10.1038/nrendo.2016.217

Nasjonal helseplan (2007–2010). (2006). (Særtrykk av St.prp. nr. 1 (2006–2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/globalassets/upload/hod/sykehus/nasjonal_helseplan_sartrykk.pdf

Nasjonal strategi for kreftområdet 2006-2009. (2006). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.regjeringen.no/no/dokumenter/nasjonal-strategi-for-kreftomradet/id446845/

Osamura, R. Y., Lopes, M. B. S., Grossman, A., Kontogeorgos, G., & Trouillas, J. (2016). Tumours of the pituitary gland. In: D. N. Louis, H. Ohgaki, O. W. Wiestler, & W. K. Cavenee (Eds.), WHO classification of tumours of the central nervous system (4. rev. ed., p. 11–63). Lyon: IARC Press.

Raverot, G., Burman, P., McCormack, A., Heaney, A., Petersenn, S., Popovic, V., . . . Dekkers, O. M. (2018). European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. European Journal of Endocrinology of the European Federation of Endocrine Societies, 178(1), G1-G24. https://doi.org/10.1530/eje-17-0796

Report 78: Prescribing, Recording, and Reporting Proton-Beam Therapy. (2007). Journal of the ICRU, 7(7).

Report 83: Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT). (2010). Journal of the ICRU, 10(1).

Raappana, A., Koivukangas, J., Ebeling, T., & Pirilä, T. (2010). Incidence of pituitary adenomas in Northern Finland in 1992-2007. Journal of Clinical Endocrinology and Metabolism, 95(9), 4268-4275. https://doi.org/10.1210/jc.2010-0537

Sammen - mot kreft: nasjonal kreftstrategi 2013-2017. (2013). Oslo: Helse- og omsorgsdepartementet. Retrieved from https://www.iccp-portal.org/system/files/plans/kreftstrategien_2013.pdf

Sheehan, J. P., Pouratian, N., Steiner, L., Laws, E. R., & Vance, M. L. (2011). Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. Journal of Neurosurgery, 114(2), 303-309. https://doi.org/10.3171/2010.5.Jns091635

Sheehan, J. P., Starke, R. M., Mathieu, D., Young, B., Sneed, P. K., Chiang, V. L., . . . Lunsford, L. D. (2013). Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. Journal of Neurosurgery, 119(2), 446-456. https://doi.org/10.3171/2013.3.Jns12766

Tjörnstrand, A., Gunnarsson, K., Evert, M., Holmberg, E., Ragnarsson, O., Rosén, T., & Filipsson Nyström, H. (2014). The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. European Journal of Endocrinology of the European Federation of Endocrine Societies, 171(4), 519-526. https://doi.org/10.1530/eje-14-0144

van Westrhenen, A., Muskens, I. S., Verhoeff, J. J. C., Smith, T. R. S., & Broekman, M. L. D. (2017). Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review. Journal of Neuro-Oncology, 135(1), 1-11. https://doi.org/10.1007/s11060-017-2530-9